US counties with more African-American patients may have fewer colorectal cancer specialists

June 15, 2009,

Each percentage point increase in the African American population in a county appears to be associated with a decrease in the number of specialists within that county who diagnose and treat colorectal cancer, according to a report in the June issue of Archives of Surgery, one of the JAMA/Archives journals. In contrast, counties with a higher percentage of Asian Americans appear to have more colorectal cancer specialists.

Despite overall declines in incidence of and death from in the general U.S. population, African Americans are more likely than other patients to die of the disease, according to background information in the article. "Minority groups have poor access to quality health care services," the authors write. "This is true of colorectal cancer care and may be related to both geographical proximity and use of surgical, gastroenterology and radiation oncology services. Without suitable access, many minority patients may present with advanced colorectal cancer and be less likely to receive appropriate adjuvant therapies [used after primary treatment to prevent cancer recurrence]."

Awori J. Hayanga, M.D., M.P.H., of the University of Michigan Medical Center, Ann Arbor, and colleagues analyzed data from the 2004 version of the Area Resource File, a nationwide database of health care, economic and demographic information. It is derived from a variety of sources and comprises data from all 3,219 counties in the United States.

"Multivariate analysis revealed a statistically significant decrease in the number of gastroenterologists and radiation oncologists with each 1 percent increase in African American population and a trend toward a decrease in colorectal surgeons in a given county," the authors write. "Each percentage point increase in the Asian American population, however, was associated with a significant increase in the number of gastroenterologists and radiation oncologists that persisted on adjusting for socioeconomic status and demographic differences within the county with a trend toward an increase in the number of colorectal surgeons."

Previous research indicates that African Americans are about 20 percent less likely to undergo colonoscopy compared with other races, and even those who have first-degree relatives with colorectal have a decreased likelihood of undergoing recommended screenings. Disparities have also been reported in the receipt of adjuvant therapies, including radiotherapy and chemotherapy, the authors note. "Perhaps the non-use of diagnostic and adjuvant therapies is related to the great distances that African Americans must travel to seek these services, plausibly outside their own residential counties. This may serve as an impediment to seeking these services despite the best intentions of referring physicians and surgeons," they write.

"Access to diagnostic and adjuvant therapies is central to timely screening, diagnosis, follow-up therapy and surveillance, without which longer-term survival may never be improved and disparities never equalized," they conclude.

Source: JAMA and Archives Journals (news : web)

Related Stories

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.